Best Life Sciences Tech Companies in Beijing, China
The 34 best Life Sciences Tech companies in Beijing, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LinkDoc.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Beijing
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Employees | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | LinkDoc 🦄 Provider of the oncology-focused database 76Moat top 15%AI top 20%Market top 25%Product top 26% All 10 signals ▾Moattop 15% AItop 20% Markettop 25% Producttop 26% Innovationtop 27% Fundingtop 31% Talentbottom 49% Globalbottom 38% Newsbottom 27% Techbottom 24% Moat: Editorial + unicorn rating 9/10 · Unicorn AI: Classified as an AI company rank vs industry peers · Fliar Intelligence Index 76/100 | $263M | 67 mo ago | Series D | Tony Zhang Founder & CEO | 2014 | 1,250 | — |
| 2 | StoneWise Provider of a software solution solution for molecular modeling | $100M | 66 mo ago | Series B | Zhou Jielong Founder & CEO | 2018 | — | — |
| 3 | DeepWise Developer of AI-based radiology image solutions primarily for cancer diagnosis 72AI top 26%Funding top 30%Market top 35%Moat top 39% All 5 signals ▾AItop 26% Fundingtop 30% Markettop 35% Moattop 39% Globalbottom 36% AI: Classified as an AI company · Product described with: ai-based, deep learning Funding: Raised $46.3M across 4 rounds · 4 rounds over 9 yrs (0.4/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $46M | 20 mo ago | Series D | — | 2017 | 200 | — |
| 4 | Hugo Biotech Developer of cloud-based pathogenic microorganism data analysis system | $34M | 72 mo ago | Series A | Han Xia Founder & CEO | 2017 | — | — |
| 5 | Deep Intelligent Pharma Developer of AI-based drug development platform 62Funding top 26%Talent top 28%AI top 30%Moat top 39% All 7 signals ▾Fundingtop 26% Talenttop 28% AItop 30% Moattop 39% Marketbottom 49% Techbottom 43% Globalbottom 29% Funding: Raised $21.6M across 3 rounds · 3 rounds over 8 yrs (0.4/yr) Talent: Analyst team rating 4/5 rank vs industry peers · Fliar Intelligence Index 62/100 | $22M | 8 mo ago | Series E | — | 2017 | 100 | — |
| 6 | Silexon Virtual high throughput screening based drug discovery platform | $15M | 61 mo ago | Deadpooled | Hainian Zeng CEO | 2018 | — | — |
| 7 | Molecular Heart Provider of chemoproteomics platform for small molecule drug discovery 24AI top 26%Funding top 38%Talent bottom 49%Tech bottom 30% All 6 signals ▾AItop 26% Fundingtop 38% Talentbottom 49% Techbottom 30% Globalbottom 29% Marketbottom 25% AI: Classified as an AI company · Product described with: ai-based, deep learning Funding: Raised $14.6M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $15M | 25 mo ago | Series A | Xu Jinbo Founder | 2022 | — | — |
| 8 | Pharmacodia Online database solutions for pharmaceutical R&D | $15M | 97 mo ago | Series B | Hongxia Ding Founder & CEO | 2013 | — | — |
| 9 | Galixir AI-based molecular drug development tool | $10M | 62 mo ago | Seed | Chengtao Li Co-Founder & CEO | 2019 | 34 | — |
| 10 | ForceClouds Sales automation SaaS provider for Life Sciences Industry | $10M | 82 mo ago | Series B | Jeff Meng Co-Founder | 2015 | 150 | — |
| 11 | Zhinuvis Provider of AI based tools for tumor gene and pathology analysis | $9M | 83 mo ago | Series B | Ling Shaoping Founder & CEO | 2015 | — | — |
| 12 | Beijing Zechuang Tiancheng Biomedical Technology Developer of clinical research learning and collaboration platform | $3M | 74 mo ago | Seed | — | 2015 | 20 | — |
| 13 | Beijing Medical Hua Mobile Medical Technology Provider of a platform for medical information | $2M | 94 mo ago | Series A | Shen Yanli Founder & CEO | 2016 | — | — |
| 14 | GigaCeuticals AI enabled platform for drug discovery | $2M | 55 mo ago | Seed | Zhengwei Xie Founder & CEO | 2018 | — | — |
| 15 | Gongyingshi B2B procurement platform for R&D labs | $2M | 117 mo ago | Series B | — | 2014 | 50 | — |
Top 12 Life Sciences Tech companies in Beijing
#1
Series E · Chaoyang, Beijing · founded 2017 · 100 employees$21.6Mraised▾
Beijing Shenzhi Yao Technology is developing AI-based drug development platform. They have developed their multi-language drug development platform which provides services including drug discovery solutions, medical writing, regulatory support, electronic data acquisition system, clinical data programming, and clinical data management support. Few clients of the company include Roche, GSK, Bayer, etc.
- Feb 2026Series E$60M
- Dec 2025Series D$50M
- Oct 2018Series B$15M
#2
Series D · Beijing, Beijing · founded 2017 · 200 employees$46.3Mraised▾
DeepWise is a developer of AI-based radiology image solutions primarily for cancer diagnosis. Its solution uses a deep learning framework to assist in medical imaging diagnosis. Claims to help in the diagnosis of breast cancer, stroke, emergency fracture, prostate cancer, and lung cancer. The company offers the cloud-based image platform, and also helps in clinical decision making and research.
- Feb 2025Series D$68.6M
- May 2021Series C—
- Dec 2020Series C—
- Jun 2019Series C—
#3
Series A · Beijing, Beijing · founded 2022$14.6Mraised▾
Provider of chemoproteomics platform for small molecule drug discovery. The company has created an AI-based macromolecular optimization and design platform "MoleculeOS" with uses data-driven deep learning methods to help biotechnologists quickly identify and generate the most suitable proteins and rapidly project laboratory research results on a large scale for industrial applications.
- Sep 2024Series A—
- Feb 2023Angel$14.6M
#4
LinkDoc 🦄Series D · Haidian, Beijing · founded 2014 · 1250 employees$263.3Mraised▾
Provider of the oncology-focused database. It is a big data company that is involved in medical information systems integration and application software development. It claims to have built a rich repository of cancer patients' medical records and comprehensive clinical data. It empowers evidence-based, personalized cancer treatment in China by providing doctors with valuable analytics derived from its oncology database.
- Mar 2021Series D—
- Sep 2020Series D$102.3M
- Jul 2018Series D$151M
- Apr 2016Series B—
#5
Series B · Haidian, Beijing · founded 2018$100Mraised▾
Stonewise provides a software solution for molecular modeling. It uses artificial intelligence-based technology for molecule design. It also gives the software for synthetic product prediction and drug knowledge mining.
- Apr 2021Series B$100M
- Sep 2020Series A—
- Mar 2020Series A—
- 2018Seed—
#6
Series A · Beijing, Beijing · founded 2017$33.5Mraised▾
HUGO BIOTECH is a developer of cloud-based pathogenic microorganism data analysis system PACE. The device is used for image capture, visualization, and biological significance analysis. The Illumina Genetic Analyzer Pipeline software is used to perform preliminary analysis on the data to obtain conversion from image capture to intensity signal value, and then calculate to base sequence. It helps to determine the DNA sequence of pathogenic microorganisms in clinical samples like cerebrospinal fluid, blood, alveolar lavage fluid, sterile body fluids, tissues, and other sources.
- Sep 2020Series A$32.1M
- Jun 2020Seed$1.4M
- Feb 2020Seed—
#7
Deadpooled · Beijing, Beijing · founded 2018$15.5Mraised▾
Silexon is the virtual high throughput screening based drug discovery platform. The platform uses artificial intelligence that helps in the integration of data for disease, targets, drug discovery, and development of small drug molecules.
- Sep 2021Series A$15.5M
- Nov 2019Seed—
- Sep 2018Seed—
#8
Seed · Beijing, Beijing · founded 2019 · 34 employees$10Mraised▾
AI-based molecular drug development tool. The company has developed software that assists with small drug molecule development and screening. It has features for developing drugs for autoimmune diseases and more.
- Aug 2021Seed—
- Dec 2020Seed—
- Aug 2020Seed$10M
#9
Series B · Beijing, Beijing · founded 2013$14.5Mraised▾
Pharmacodia provides a big data and information service solutions for pharmaceutical R&D. Its flagship product Drug Delivery Data V.2.0 is an online platform that hosts a database on drugs, global approvals, clinical trials, patent information, and literature.
- Sep 2018Series B—
- May 2017Series B$14.5M
- Jun 2015Series A—
#10
Series B · Beijing, Beijing · founded 2015 · 150 employees$10Mraised▾
ForceClouds is a sales automation SaaS provider for Life Sciences Industry. The platform helps clients in customer relationship management, regional sales management, sales targets distribution, sales commission management and sales performance management. Claims to have over 30,000 users from the global top 500 Pharmaceuticals, Medical Devices and nutritional health companies' sales staff.
- Dec 2019Series B$10M
- 2017Series A—
#11
Series B · Beijing, Beijing · founded 2015$8.5Mraised▾
Provider of AI-based tools for tumor gene and pathology analysis. The company is offering two flagship solutions, the iGeenome Cloud for genetic detection and research, and the iPhenomeCloud, a phenotype cloud for pathology analysis and management. The company aims to cater to third-party IVD testing institutions, hospital pathology, and cancer clinical and drug research institutions by offering them tumor genomic and pathological data analysis.
- Nov 2019Series B$8.5M
- 2019Series A—
- Seed—
#12
Seed · Chaoyang, Beijing · founded 2015 · 20 employees$3.5Mraised▾
Developed of clinical research learning and collaboration platform. The platform also offers services like clinical research data collection and management, data analysis and mining, and the exchange of scientific research results and application transformation. The software is SaaS and artificial intelligence-based.
- Aug 2020Seed$2.9M
- Sep 2018Seed$583.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Beijing is moving
A read on the academic research around Biotechnology in Beijing — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 276 papers.
- Beijing Academy of Agricultural and Forestry Sciences31
- Beijing Technology and Business University30
- Beijing Forestry University19
- Beijing University of Chemical Technology18
- Beijing University of Agriculture16
- Transcription factor1→7
- Transcriptome1→5
- Mutant1→3
- Transcription (linguistics)1→3
- Cleavage (geology)1→3
- Metabolomics8
- Agriculture7
- Fermentation6
- Gene5
- Production (economics)5
- Key (lock)4
- Food safety3
- Agriculture3
- Drug development3
- Human health3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.